CORTELEZZI, AGOSTINO
CORTELEZZI, AGOSTINO
Dipartimento di Oncologia ed Emato-Oncologia
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years : NILG ALL 10/07
2020 R. Bassan, C. Pavoni, T. Intermesoli, O. Spinelli, M. Tosi, E. Audisio, F. Marmont, C. Cattaneo, E. Borlenghi, S. Cortelazzo, I. Cavattoni, M. Fumagalli, D. Mattei, C. Romani, A. Cortelezzi, N. Fracchiolla, F. Ciceri, M. Bernardi, A.M. Scattolin, L. Depaoli, A. Masciulli, E. Oldani, A. Rambaldi
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06
2020 C. Caprioli, F. Lussana, S. Salmoiraghi, R. Cavagna, K. Buklijas, L. Elidi, P. Zanghi', A. Michelato, F. Delaini, E. Oldani, T. Intermesoli, A. Grassi, G. Gianfaldoni, F. Mannelli, D. Ferrero, E. Audisio, E. Terruzzi, L. De Paoli, C. Cattaneo, E. Borlenghi, I. Cavattoni, M. Tajana, A.M. Scattolin, D. Mattei, P. Corradini, L. Campiotti, F. Ciceri, M. Bernardi, E. Todisco, A. Cortelezzi, B. Falini, C. Pavoni, R. Bassan, O. Spinelli, A. Rambaldi
Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial
2020 L. Cicconi, U. Platzbecker, G. Avvisati, F. Paoloni, C. Thiede, M. Vignetti, P. Fazi, F. Ferrara, M. Divona, F. Albano, F. Efficace, M. Sborgia, E. Di Bona, M. Breccia, E. Borlenghi, R. Cairoli, A. Rambaldi, L. Melillo, G. La Nasa, W. Fiedler, P. Brossart, B. Hertenstein, H.R. Salih, O. Annibali, M. Wattad, M. Lubbert, C.H. Brandts, M. Hanel, C. Rollig, N. Schmitz, H. Link, C. Frairia, C. Fozza, A. Maria D'Arco, N. Di Renzo, A. Cortelezzi, F. Fabbiano, K. Dohner, A. Ganser, H. Dohner, S. Amadori, F. Mandelli, M.T. Voso, G. Ehninger, R.F. Schlenk, F. Lo-Coco
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL)
2019 R. Cassin, V. Mattiello, M. Viltadi, D. D'Aliberti, R. Piazza, C. Gambacorti-Passerini, U. Gianelli, A. Neri, A. Cortelezzi, G. Reda
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo)
2019 A. Candoni, A. Rambaldi, R. Fanin, A. Velardi, W. Arcese, F. Ciceri, D. Lazzarotto, F. Lussana, J. Olivieri, G. Grillo, M. Parma, B. Bruno, F. Sora, P. Bernasconi, R. Saccardi, R. Foà, M. Sessa, P. Bresciani, F. Giglio, A. Picardi, A. Busca, S. Sica, K. Perruccio, E. Zucchetti, E. Diral, A.P. Iori, A.A. Colombo, S. Tringali, S. Santarone, G. Irrera, S. Mancini, F. Zallio, M. Malagola, F. Albano, A.M. Carella, A. Olivieri, C. Tecchio, A. Dominietto, A. Vacca, R. Sorasio, E. Orciuolo, A.M. Risitano, S.N. Leotta, A. Cortelezzi, S. Mammoliti, E. Oldani, F. Bonifazi
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia
2019 G. Reda, R. Cassin, M. Gentile, F.R. Mauro, D. Giannarelli, B. Fattizzo, M. Barbieri, I. Silvestris, S. Fabris, F. Morabito, A. Neri, W. Barcellini, A. Cortelezzi
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML
2019 R. Bassan, T. Intermesoli, A. Masciulli, C. Pavoni, C. Boschini, G. Gianfaldoni, F. Marmont, I. Cavattoni, D. Mattei, E. Terruzzi, L. De Paoli, C. Cattaneo, E. Borlenghi, F. Ciceri, M. Bernardi, A.M. Scattolin, E. Todisco, L. Campiotti, P. Corradini, A. Cortelezzi, D. Ferrero, P. Zanghì, E. Oldani, O. Spinelli, E. Audisio, S. Cortelazzo, A. Bosi, B. Falini, E.M. Pogliani, A. Rambaldi
Secondary acute myeloid leukaemia in elderly patients : Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions : an analysis of 280 patients by the network rete ematologica lombarda (REL)
2018 E. Borlenghi, C. Pagani, P. Zappasodi, M. Bernardi, C. Basilico, E. Todisco, N. Fracchiolla, V. Mancini, M. Turrini, M. Da Vià, E. Sala, C. Cattaneo, M. Petullà, F. Serana, A. Ferrario, R. Cairoli, A. Cortelezzi, A. Santoro, C. Castagnola, G. Rossi
Immunoglobulin heavy chain variable region gene (IGHV) and prediction of time to first treatment (TTFT) in patients with chronic lymphocytic leukemia (CLL): Mutational load or mutational status? Analysis of 1003 cases
2018 F. Morabito, T.D. Shanafelt, M. Gentile, G. Reda, F.R. Mauro, D. Rossi, N. Di Renzo, S. Molica, F. Angrilli, A. Chiarenza, G. Cutrona, K.G. Chaffee, S.A. Parikh, G. Tripepi, G. D'Arrigo, E. Vigna, A.G. Recchia, A. Cortelezzi, G. Gaidano, F. Di Raimondo, F. Fais, R. Foà, A. Neri, M. Ferrarini
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment
2018 M. Gentile, T.D. Shanafelt, F.R. Mauro, G. Reda, D. Rossi, L. Laurenti, M.I. Del Principe, G. Cutrona, I. Angeletti, M. Coscia, Y. Herishanu, A. Chiarenza, S. Molica, S. Ciolli, N. Goldschmidt, F. Angrilli, A. Giordano, A. Rago, O. Bairey, G. Tripepi, K.G. Chaffee, P.A. Sameer, E. Vigna, K. Zirlik, L. Shvidel, I. Innocenti, A.G. Recchia, F. Di Raimondo, G. Del Poeta, A. Cortelezzi, A. Neri, M. Ferrarini, G. Gaidano, N.E. Kay, A. Polliack, R. Foà, F. Morabito
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study
2018 G. Reda, B. Fattizzo, R. Cassin, V. Mattiello, T. Tonella, D. Giannarelli, F. Massari, A. Cortelezzi
Heterogeneity among different myeloproliferative neoplasms associated with splanchnic vein thrombosis
2018 D. Cattaneo, N. Orofino, C. Bucelli, V. Mattiello, P. Bianchi, U. Gianelli, A. Cortelezzi, A. Iurlo
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
2018 G. Reda, M. Riva, B. Fattizzo, R. Cassin, D. Giannarelli, M. Pennisi, A. Freyrie, R. Cairoli, A. Molteni, A. Cortelezzi
Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms
2018 D. Cattaneo, U. Gianelli, P. Bianchi, A. Cortelezzi, A. Iurlo
Prevalence and clinical significance of small PNH clones in patiens with primary autoimmune hemolytic anemia
2018 B. Fattizzo, A. Zaninoni, R. Pasquale, L. Cro, A. Dunlop, A. Cortelezzi, A. Kulasekararaj, W. Barcellini
Paroxysmal Nocturnal Hemoglobinuria (Pnh) : Brain Mri Ischemic Lesions in Neurologically Asymtomatic Patients
2018 W. Barcellini, E. Scola, S. Lanfranconi, M. Grottaroli, F. Binda, B. Fattizzo, A. Zaninoni, G. Valcamonica, C.M. Cinnante, C. Boschetti, M. Buoli, C.A. Altamura, N. Bresolin, F. Triulzi, A. Zanella, A. Cortelezzi
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia
2018 G. Reda, R. Cassin, A. Artoni, B. Fattizzo, A. Lecchi, S. La Marca, P. Bucciarelli, G.V. Levati, F. Peyvandi, A. Cortelezzi
Circulating tumor DNA as a liquid biopsy in plasma cell dyscrasias
2018 B. Gerber, M. Manzoni, V. Spina, A. Bruscaggin, M. Lionetti, S. Fabris, M. Barbieri, G. Ciceri, A. Pompa, G. Forestieri, E. Lerch, P. Servida, F. Bertoni, E. Zucca, M. Ghielmini, A. Cortelezzi, F. Cavalli, G. Stussi, L. Baldini, D. Rossi, A. Neri
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab
2018 M. Gentile, T.D. Shanafelt, G. Reda, F.R. Mauro, K. Zirlik, S. Ciolli, L. Laurenti, M.I. Del Principe, D. Rossi, N. Di Renzo, S. Molica, F. Angrilli, M. Coscia, A. Chiarenza, A. Giordano, G. Cutrona, K.G. Chaffee, S.A. Parikh, G. Uccello, I. Innocenti, G. Tripepi, G. D'Arrigo, E. Vigna, A.G. Recchia, Y. Herishanu, L. Shvidel, T. Tadmor, A. Cortelezzi, G. Del Poeta, G. Gaidano, F. Di Raimondo, A. Neri, M. Ferrarini, R. Foà, A. Polliack, F. Morabito
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome–positive acute lymphoblastic leukemia
2018 M. Sciumè, N.S. Fracchiolla, A. Cortelezzi